KEYNOTE-061: Response to subsequent therapy following second-line pembrolizumab or paclitaxel in patients with advanced gastric or gastroesophageal junction adenocarcinoma

Yoon H., Fuchs C., ÖZGÜROĞLU M., Bang Y., Di Bartolomeo M., Mandala M., ...More

ESMO 22nd World Congress on Gastrointestinal Cancer, ELECTR NETWORK, 1 - 04 July 2020, vol.31, (Summary Text)

  • Publication Type: Conference Paper / Summary Text
  • Volume: 31
  • Doi Number: 10.1016/j.annonc.2020.04.065
  • Country: ELECTR NETWORK
  • Istanbul University Affiliated: No